Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease
Clinical trial NCT04157933 · COMPLETED
Trial details
- NCT number
- NCT04157933
- Sponsor
- Alexza Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2020-02-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.